{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:41:58Z","timestamp":1791495718401,"version":"4.3.4"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,1]]},"DOI":"10.2146\/ajhp120291","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T19:58:26Z","timestamp":1376423906000},"page":"1483-1494","source":"Crossref","is-referenced-by-count":74,"title":["Sulfonamide cross-reactivity: Is there evidence to support broad cross-allergenicity?"],"prefix":"10.1093","volume":"70","author":[{"given":"Nicole R.","family":"Wulf","sequence":"first","affiliation":[{"name":"First Databank, Inc., St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Matuszewski","sequence":"additional","affiliation":[{"name":"First Databank, Inc., South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041607534670500_b1-0701483","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1592\/phco.24.9.856.36106","article-title":"Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group","volume":"24","author":"Brackett","year":"2004","journal-title":"Pharmacotherapy."},{"key":"2019041607534670500_b2-0701483","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00007611-200194080-00014","article-title":"Practical issues in the management of hypersensitivity reactions: sulfonamides","volume":"94","author":"Tilles","year":"2001","journal-title":"South Med J."},{"key":"2019041607534670500_b3-0701483","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom","year":"2003","journal-title":"N Engl J Med."},{"key":"2019041607534670500_b4-0701483","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1592\/phco.26.4.551","article-title":"Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients","volume":"26","author":"Hemstreet","year":"2006","journal-title":"Pharmacotherapy."},{"key":"2019041607534670500_b5-0701483","volume-title":"Bleph-10 (sulfacetamide) package insert","year":"2007"},{"key":"2019041607534670500_b6-0701483","volume-title":"Sulfadiazine package insert","year":"2008"},{"key":"2019041607534670500_b7-0701483","volume-title":"Bactrim DS (sulfamethoxazole, trimethoprim) package insert","year":"2010"},{"key":"2019041607534670500_b8-0701483","volume-title":"AVC Vaginal (sulfanilamide) package insert","year":"2011"},{"key":"2019041607534670500_b9-0701483","volume-title":"Azulfidine (sulfasalazine) package insert","year":"2011"},{"key":"2019041607534670500_b10-0701483","volume-title":"Gantrisin (sulfisoxazole) package insert","year":"1997"},{"key":"2019041607534670500_b11-0701483","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11882-007-0029-8","article-title":"Sulfonamide allergy and cross-reactivity","volume":"7","author":"Brackett","year":"2007","journal-title":"Curr Allergy Asthma Rep."},{"key":"2019041607534670500_b12-0701483","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11882-002-0033-y","article-title":"Allergic adverse reactions to sulfonamides","volume":"2","author":"Choquet-Kastylevsky","year":"2002","journal-title":"Curr Allergy Asthma Rep."},{"key":"2019041607534670500_b13-0701483","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00002018-200124040-00001","article-title":"Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of \u2018sulfa\u2019 allergy","volume":"24","author":"Knowles","year":"2001","journal-title":"Drug Saf."},{"key":"2019041607534670500_b14-0701483","first-page":"72","article-title":"The sulfonamide group as a structural alert: a distorted story?","volume":"11","author":"Smith","year":"2008","journal-title":"Curr Opin Drug Discov Devel."},{"key":"2019041607534670500_b15-0701483","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.0105-1873.2004.00274.x","article-title":"Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing","volume":"51","author":"Tornero","year":"2004","journal-title":"Contact Dermatitis."},{"key":"2019041607534670500_b16-0701483","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1345\/aph.1G642","article-title":"Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure","volume":"40","author":"Verdel","year":"2006","journal-title":"Ann Pharmacother."},{"key":"2019041607534670500_b17-0701483","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702453","article-title":"Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity","volume":"126","author":"Naisbitt","year":"1999","journal-title":"Br J Pharmacol."},{"key":"2019041607534670500_b18-0701483","unstructured":"Food and Drug Administration. Drugs@ FDA [searchable index]. www.access-data.fda.gov\/scripts\/cder\/drugsatfda\/ (accessed 2012 Feb 6)."},{"key":"2019041607534670500_b19-0701483","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1345\/aph.1E350","article-title":"Sulfonamide cross-reactivity: fact or fiction?","volume":"39","author":"Johnson","year":"2005","journal-title":"Ann Pharmacother."},{"key":"2019041607534670500_b20-0701483","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0091-6749(87)90361-7","article-title":"Studies of human IgE to a sulfonamide determinant","volume":"79","author":"Carrington","year":"1987","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b21-0701483","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions: the reactive metabolite syndromes","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet."},{"key":"2019041607534670500_b22-0701483","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0161-5890(88)90050-8","article-title":"Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole","volume":"25","author":"Harle","year":"1988","journal-title":"Molecular Immunol."},{"key":"2019041607534670500_b23-0701483","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b24-0701483","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.jaci.2004.01.084","article-title":"Patients with sulfonamide antimicrobial \u201callergy\u201d: are they able to tolerate sulfonamide-containing non-antimicrobial agents?","volume":"114","author":"Morgan","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b25-0701483","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J Immunol."},{"key":"2019041607534670500_b26-0701483","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2003.11.030","article-title":"Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity","volume":"113","author":"Depta","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b27-0701483","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI12118","article-title":"T-cell involvement in drug-induced acute generalized exanthematous pustulosis","volume":"107","author":"Britschgi","year":"2001","journal-title":"J Clin Invest."},{"key":"2019041607534670500_b28-0701483","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/abio.2001.5467","article-title":"Use of optical biosensor technology to study immunological cross-reactivity between different sulfonamide drugs","volume":"300","author":"Ahmad","year":"2002","journal-title":"Analyt Biochem."},{"key":"2019041607534670500_b29-0701483","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med."},{"key":"2019041607534670500_b30-0701483","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","article-title":"Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo","volume":"133","author":"Naisbitt","year":"2001","journal-title":"Br J Pharmacol."},{"key":"2019041607534670500_b31-0701483","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0091-6749(91)90186-R","article-title":"Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-l-tyrosine","volume":"88","author":"Gruchalla","year":"1991","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b32-0701483","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1992.57","article-title":"Sulfamethoxazole is metabolized to the hydroxylamine in humans","volume":"51","author":"Cribb","year":"1992","journal-title":"Clin Pharmacol Ther."},{"key":"2019041607534670500_b33-0701483","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/ajem.2002.33774","article-title":"Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide","volume":"20","author":"Gallerani","year":"2002","journal-title":"Am J Emerg Med."},{"key":"2019041607534670500_b34-0701483","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1034\/j.1600-0536.2001.450416.x","article-title":"Allergic contact blepharoconjunctivitis from dorzolamide","volume":"45","author":"Mancuso","year":"2001","journal-title":"Contact Dermatitis."},{"key":"2019041607534670500_b35-0701483","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bjo.82.5.e584","article-title":"Anaphylactic shock after a single oral intake of acetazolamide","volume":"82","author":"Tzanakis","year":"1998","journal-title":"Br J Ophthalmol."},{"key":"2019041607534670500_b36-0701483","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajo.2004.02.019","article-title":"Presumed \u201csulfa allergy\u201d in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality?","volume":"138","author":"Lee","year":"2004","journal-title":"Am J Ophthalmol."},{"key":"2019041607534670500_b37-0701483","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1592\/phco.23.4.551.32118","article-title":"Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs","volume":"23","author":"Glasser","year":"2003","journal-title":"Pharmacotherapy."},{"key":"2019041607534670500_b38-0701483","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1034\/j.1398-9995.2003.00116.x","article-title":"Anaphylactic drug reaction to celecoxib and sulfamethoxazole: cross-reactivity or coincidence?","volume":"58","author":"Schuster","year":"2003","journal-title":"Allergy."},{"key":"2019041607534670500_b39-0701483","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1592\/phco.22.8.637.33200","article-title":"Celecoxib-induced erythema multiforme with glyburide cross-reactivity","volume":"22","author":"Ernst","year":"2002","journal-title":"Pharmacotherapy."},{"key":"2019041607534670500_b40-0701483","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0105-1873.2005.0483d.x","article-title":"Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test","volume":"52","author":"Jaeger","year":"2005","journal-title":"Contact Dermatitis."},{"key":"2019041607534670500_b41-0701483","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000051790","article-title":"Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides","volume":"203","author":"Kaur","year":"2001","journal-title":"Dermatology."},{"key":"2019041607534670500_b42-0701483","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000051569","article-title":"Allergic skin reaction to celecoxib","volume":"201","author":"Grob","year":"2000","journal-title":"Dermatology."},{"key":"2019041607534670500_b43-0701483","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1445-5994.2006.01184.x","article-title":"Celecoxib allergies and cross-reactivity","volume":"36","author":"Ch\u2019ng","year":"2006","journal-title":"Intern Med J."},{"key":"2019041607534670500_b44-0701483","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7326\/0003-4819-134-3-200102060-00028","article-title":"Celecoxib-induced cholestatic hepatitis","volume":"134","author":"Galan","year":"2001","journal-title":"Ann Intern Med."},{"key":"2019041607534670500_b45-0701483","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.160.4.553","article-title":"Celecoxib-induced acute pancreatitis and hepatitis: a case report","volume":"160","author":"Carrillo-Jimenez","year":"2000","journal-title":"Arch Intern Med."},{"key":"2019041607534670500_b46-0701483","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2004.10.045","article-title":"Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole","volume":"115","author":"Fontaine","year":"2005","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b47-0701483","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1067\/mai.2003.1465","article-title":"Selective celecoxib-associated anaphylactoid reaction","volume":"111","author":"Gagnon","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b48-0701483","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1398-9995.2006.01270.x","article-title":"Sulfonamide allergy without cross-reactivity to celecoxib","volume":"62","author":"Figueroa","year":"2007","journal-title":"Allergy."},{"key":"2019041607534670500_b49-0701483","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0149-2918(00)87238-0","article-title":"Immunologic tolerability profile of celecoxib","volume":"21","author":"Patterson","year":"1999","journal-title":"Clin Ther."},{"key":"2019041607534670500_b50-0701483","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-200326030-00004","article-title":"Safety of celecoxib in individuals allergic to sulfonamide. A pilot study","volume":"26","author":"Shapiro","year":"2003","journal-title":"Drug Saf."},{"key":"2019041607534670500_b51-0701483","volume-title":"Celebrex (celecoxib) package insert","year":"2011"},{"key":"2019041607534670500_b52-0701483","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0301-0546(03)79210-6","article-title":"Anaphylaxis to oral furosemide","volume":"31","author":"Dominguez-Ortega","year":"2003","journal-title":"Allergol Immunopathol (Madr)."},{"key":"2019041607534670500_b53-0701483","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1081-1206(10)60274-8","article-title":"Rapid oral desensitization to furosemide","volume":"103","author":"Alim","year":"2009","journal-title":"Ann Allergy Asthma Immunol."},{"key":"2019041607534670500_b54-0701483","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archinte.163.1.116","article-title":"Ethacrynic acid and the sulfa-sensitive patient","volume":"163","author":"Wall","year":"2003","journal-title":"Arch Intern Med."},{"key":"2019041607534670500_b55-0701483","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0091-6749(87)90004-2","article-title":"Anaphylaxis to intravenous furosemide","volume":"80","author":"Hansbrough","year":"1987","journal-title":"J Allergy Clin Immunol."},{"key":"2019041607534670500_b56-0701483","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1345\/aph.1G314","article-title":"Probable loop diuretic induced pancreatitis in a sulfonamide-allergic patient","volume":"40","author":"Juang","year":"2006","journal-title":"Ann Pharmacother."},{"key":"2019041607534670500_b57-0701483","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardfail.2005.03.005","article-title":"A successful rapid desensitization protocol in a loop diuretic allergic patient","volume":"11","author":"Juang","year":"2005","journal-title":"J Card Fail."},{"key":"2019041607534670500_b58-0701483","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-138-4-200302180-00025","article-title":"Furosemide challenge in patients with heart failure and adverse reactions to sulfa-containing diuretics","volume":"138","author":"Earl","year":"2003","journal-title":"Ann Intern Med."},{"key":"2019041607534670500_b59-0701483","first-page":"21","article-title":"Thrombocytopenia due to sulfonamide cross-sensitivity","volume":"81","author":"Bretza","year":"1982","journal-title":"Wis Med J."},{"key":"2019041607534670500_b60-0701483","first-page":"235","article-title":"Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylurea","volume":"71","author":"Bukhalo","year":"2003","journal-title":"Cutis."},{"key":"2019041607534670500_b61-0701483","first-page":"551","article-title":"Systemic contact dermatitis from Orinase and Diabinese in diabetics with para-amino hypersensitivity","volume":"29","author":"Fisher","year":"1982","journal-title":"Cutis."},{"key":"2019041607534670500_b62-0701483","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bmj.295.6609.1313","article-title":"Skin reactions and fever with indapamide","volume":"295","author":"Stricker","year":"1987","journal-title":"BMJ."},{"key":"2019041607534670500_b63-0701483","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjopharm.2006.12.002","article-title":"Hydrochlorothiazide-induced angioedema in a patient allergic to sulfonamide antibiotics: evidence from a case report and a review of the literature","volume":"4","author":"Ruscin","year":"2006","journal-title":"Am J Geriatr Pharmacother."},{"key":"2019041607534670500_b64-0701483","first-page":"196","article-title":"Vesiculobullous rash in a patient with systemic lupus erythematosus","volume":"70","author":"Landor","year":"1993","journal-title":"Ann Allergy."},{"key":"2019041607534670500_b65-0701483","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1592\/phco.29.3.357","article-title":"Severe allergic reaction to hydrochlorothiazide mimicking septic shock","volume":"29","author":"Mineo","year":"2009","journal-title":"Pharmacotherapy."},{"key":"2019041607534670500_b66-0701483","first-page":"253","article-title":"Fixed drug eruption induced by indapamide. Cross-reactivity with sulfonamides","volume":"8","author":"De Barrio","year":"1998","journal-title":"J Investig Allergol Clin Immunol."},{"key":"2019041607534670500_b67-0701483","first-page":"118","article-title":"Erythema multiforme and angioedema with indapamide and sertraline","volume":"51","author":"Gales","year":"1994","journal-title":"Am J Hosp Pharm."},{"key":"2019041607534670500_b68-0701483","first-page":"372","article-title":"Lack of cross-reactivity to sumatriptan in patients allergic to sulfonamides: a retrospective chart review","volume":"39","author":"Newman","year":"1999","journal-title":"Headache."},{"key":"2019041607534670500_b69-0701483","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1081-1206(10)63559-4","article-title":"Amprenavir-induced maculopapular exanthema followed by desensitization in a patient with late-stage human immunodeficiency virus","volume":"96","author":"Kohli-Pamnani","year":"2006","journal-title":"Ann Allergy Asthma Immunol."},{"key":"2019041607534670500_b70-0701483","volume-title":"Lexiva (fosamprenavir) package insert","year":"2010"},{"key":"2019041607534670500_b71-0701483","volume-title":"Agenerase (amprenavir) package insert","year":"2006"},{"key":"2019041607534670500_b72-0701483","unstructured":"Food and Drug Administration. Drugs @FDA. Aptivus (tipranavir) label and approval history (NDA 021814). www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Label_ApprovalHistory (accessed 2012 Feb 16)."},{"key":"2019041607534670500_b73-0701483","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1111\/j.1365-2230.2009.03508.x","article-title":"Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus","volume":"34","author":"Pahk","year":"2009","journal-title":"Clin Exper Dermatol."},{"key":"2019041607534670500_b74-0701483","volume-title":"Flomax (tamsulosin) package insert","year":"2011"},{"issue":"suppl 7","key":"2019041607534670500_b75-0701483","first-page":"269","article-title":"Sulfa drug allergies and zonisamide","volume":"42","author":"McJilton","year":"2001","journal-title":"Epilepsia."},{"issue":"suppl 7","key":"2019041607534670500_b76-0701483","first-page":"209","article-title":"Do allergic reactions to sulfonamide antibiotics predict allergy to zonisamide?","volume":"43","author":"Ritter","year":"2002","journal-title":"Epilepsia."},{"key":"2019041607534670500_b77-0701483","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1600-0625.2008.00748.x","article-title":"Predicting possible zonisamide hypersensitivity syndrome","volume":"17","author":"Neuman","year":"2008","journal-title":"Exp Dermatol."},{"key":"2019041607534670500_b78-0701483","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0536.1992.tb03263.x","article-title":"Concomitant sensitization to enoxolone and mafenide in a topical medicament","volume":"27","author":"Fernandez","year":"1992","journal-title":"Contact Dermatitis."},{"key":"2019041607534670500_b79-0701483","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-0536.1993.tb03417.x","article-title":"Allergic contact dermatitis from topical mafenide","volume":"28","author":"Sanz de Galdeano","year":"1993","journal-title":"Contact Dermatitis."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/70\/17\/1483\/28456510\/ajhp1483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T12:03:03Z","timestamp":1555416183000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/70\/17\/1483\/5112341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":79,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2013,9,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp120291","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,9,1]]},"published":{"date-parts":[[2013,9,1]]}}}